P084 Dissecting the role of PPARgamma in intestinal fibrosis: EMT-activator ZEB1 as new molecular target

P084 Dissecting the role of PPARgamma in intestinal fibrosis: EMT-activator ZEB1 as new molecular target S. Speca1 *, V. Flati2, C. Rousseaux3, C. Dubuquoy3, A. Langlois4, L. Dubuquoy1, B. Bertin4, S. Bellinvia5, P. Desreumaux1,6, G. Latella7. 1INSERM, U995, Lille, France, 2University of L’Aquila, Scienze cliniche applicate e biotecnologiche, L’Aquila, Italy, 3Intestinal Biotech Development, Intestinal Biotech Development, Lille, France, 4Universite Lille-Nord de France, U995, Lille, France, 5Giuliani Spa, Milan, Italy, 6CHRU Lille, Gastroenterology, Lille, France, 7University of L’Aquila, Medicina clinica, sanita pubblica, scienze della vita e dell’ambiente, L’Aquila, Italy